Several studies have suggested that caspase-3 overexpression and enhanced apoptotic activity, is observed in breast carcinomas compared with controls; however, none have shown significant associations between protein expression and patient prognosis [21, 35]. This evidence concerns the gene CASP3 and breast carcinoma.